Fragile X Syndrome

• Phase 2 Study of STX209 to Promote Language and Communication in Children with Fragile X Syndrome
• Phase 3 Study of STX209 for Social Withdrawal in Fragile X Syndrome (Ages 5-11)
• Phase 3 Study of STX209 for Social Withdrawal in Fragile X Syndrome (Ages 12-25)

Autism

• Phase 2b Study of STX209 for Social Withdrawal in Autism Spectrum Disorders (Ages 5-21)